(n= 219). A total of 6,300 subjects were finally included in the present study. The study protocol was approved by the Korean Ministry of Health and Welfare, and the institutional review board of the Korean Center for Disease Control and Prevention approved the study protocol. All subjects provided informed written consent.
Anthropometric measurements
We measured waist circumference to the nearest 0.1 cm on a horizontal plane at the midpoint between the costal margin and the iliac crest at the end of normal expiration. Height and weight were measured to the nearest 0.1 cm and 0.1 kg, respectively, with the subject wearing lightweight clothing. Weight (kg) was divided by the square of height (m 2 ) to calculate the body mass index (BMI). We measured systolic blood pressure and diastolic blood pressure (BP) 3 times using a mercury sphygmomanometer (Baumanometer; W. A. Baum Co., Inc., Copiague, NY, USA). Each subject was rested and seated for at least 5 minutes before BP measurement. The final BP value was obtained by taking the average of the second and third BP measurements. We used average BP levels for statistical analysis.
Biochemical measurements
After a minimum of 8 hours of fasting, blood samples were obtained. The serum levels of TC, TG, LDL-C and HDL-C were measured enzymatically using a Hitachi Automatic Analyzer 7600 (Hitachi, Tokyo, Japan) after the samples were delivered to the Central Testing Institute in Seoul, Korea. LDL-C level was calculated using the Friedewald's formula in subjects with a TG level ≤400 mg/dL and was measured directly using commercially available kits (Cholestest ® LDL; Sekisui Medical, Tokyo, Japan) in subjects with a TG level >400 mg/dL.
General health behaviors
We divided subjects into 3 groups according to smoking status: 1) nonsmokers: those who never smoked or had smoked <100 cigarettes in their whole life; 2) exsmokers: those who had smoked in the past but had stopped smoking; and 3) current smokers: those who were currently smoking and had smoked ≥100 cigarettes. In terms of alcohol intake, mild to moderate drinking was defined as <3 glasses a day (15~30g/ day) and heavy drinking was defined as ≥3 glasses a day (≥30g/day). We surveyed physical activities using the International Physical Activity Questionnaire [25] . and lower BMD was also associated with hypercholesterolemia in some human studies [15] [16] [17] , but others found that BMD was positively associated with hypercholesterolemia or there was no relationship between the 2 diseases [19, 20] .
The prevalence of dyslipidemia is increasing in South Korea, with a rate of 32.4% in 1998 and 44.1% in 2005. In particular, the prevalence of dyslipidemia has been shown to be higher in men than in women, with values of 38.4% in 1998 and 54.5% in 2005 [21] . The prevalence of osteoporosis in men is also increasing in South Korea [22] . Some Korean studies have investigated the relationship between osteoporosis and dyslipidemia, but the results were not inconsistent, and they recruited participants only in single university hospitals or health promotion centers [23, 24] . Therefore, we studied the relationship between BMD and dyslipidemia in Korean men using representative data from the 2008-2010 Korean National Health Examination and Nutrition Surveys (KNHANES).
Materials and Methods

Subjects
We analyzed data from the KNHANES conducted between 2008 and 2010 by the Korean Center for Disease Control and Prevention and the Korean Ministry of Health and Welfare. We included data from 12,417 men between the ages of 19 and 85 years. The survey was comprised of 3 parts: a health interview survey, a nutrition survey, and a health examination survey. The KNHANES includes non-institutionalized civilians and is a nationwide study that uses a stratified and multistage probability sampling design by a rolling survey sampling model. We built the sampling units on household unit data from the 2005 National Census Registry, which includes age, sex, and geographic area. Trained interviewers conducted face-to-face interviews using a structured questionnaire.
We included in the present analysis only men who were measured for BMD (n=9,459). Subjects with thyroid disease, cirrhosis, chronic hepatitis B or C, chronic kidney disease, pulmonary and extrapulmonary tuberculosis, and cancer were excluded. Subjects with a history of osteoporosis treatment were also excluded, as were those who did not answer questions about past medical history and those who had not fasted for more than 8 hours before blood samples were taken. Subjects who had taken anti-dyslipidemic medications were excluded used for continuous variables. Using multivariable logistic regression analysis, odds ratios (ORs) and 95% confidence intervals (CIs) of an increase in BMD (per standard deviation) for variable indexes of dyslipidemia were obtained. And we also show relationship between BMD and variable indexes of dyslipidemia by multiple regression analysis (Supplement Table 1 ). All statistical tests were 2-tailed, and statistical significance was defined as p<0.05. SAS software package version 9.2 for Windows (SAS Institute, Cary, NC, USA) was used for all analyses.
Results
There were differences between men with dyslipidemia and without dyslipidemia in all baseline characteristics in this study, including anthropometric measurements, health behavior, socioeconomic status, biochemical parameters, and nutritional assessment (Table 1) . On average, men with dyslipidemia were older, had lower height, and had higher BMI and waist circumference than men without dyslipidemia (p<0.001). In addition, a higher percentage of men with dyslipidemia were ex-smokers and current smokers and were sedentary in regard to physical activity. More men with dyslipidemia were mild to moderate drinkers and heavy drinkers compared with men without dyslipidemia. Levels of education and monthly household income were not significantly different between the 2 groups (p=0.883 and p=0.269, respectively). Total energy and fat intake were higher in men with dyslipidemia compared with men without dyslipidemia (p<0.005), as were lipid levels and other parameters for dyslipidemia except HDL-C (p<0.001). BMDs were not significantly different between the 2 groups except FN (p<0.001). Table 2 shows average levels of parameters for dyslipidemia according to socioeconomic and general health behaviors. Average levels of all parameters for dyslipidemia were different among the 3 age groups (all p<0.001). All average levels of parameters for dyslipidemia were the highest in the middle-aged group (40 years ≤ age < 65 years) except HDL-C. The 2 education level groups had significantly different levels of TC, LDL-C, TC/HDL-C, NHDL-C, and LDL-C/HDL-C (p<0.001). All levels of other parameters for dyslipidemia were different among the 3 alcohol consumption groups except TC (all p<0.01). In regard to smoking status, means of all parameters for dyslipidemia were different except HDL-C, LDL-C, and LDL-C/HDL-C Subjects were divided into 3 physical activity groups: sedentary (<600 metabolic equivalents [METs]/week), minimally active (600-3000 METs/week), and healthenhancing physical activity (>3000 METs/week).
Definition of dyslipidemia
Dyslipidemia was defined according to the criteria of the National Cholesterol Education Program Adult Treatment Panel III [1] . Dyslipidemia was defined on the basis of the presence of one or more of the following: 1) TC level ≥240 mg/dL, 2) HDL-C level <40 mg/ dL, 3) LDL-C level ≥160 mg/dL, 4) TG level ≥200 mg/ dL, and 5) use of one or more anti-dyslipidemia drugs. A high TC level was defined as a TC level ≥240 mg/ dL, and a low HDL-C level was defined as an HDL-C level <40 mg/dL. A high LDL-C level was defined as an LDL-C level ≥160 mg/dL, and high TG was defined as a TG level ≥200 mg/dL. In addition, other surrogate parameters for dyslipidemia were calculated, including non-HDL-C (NHDL-C), TG/HDL-C, TC/HDL-C, and LDL-C/HDL-C. NHDL-C level was calculated as TC level minus HDL-C level, and a high level was defined as ≥160 mg/dL [26] . A high TG/HDL-C level was defined as >3.8, because it is known to be correlated with the risk of CVD [27] . A high TC/HDL-C level was defined as ≥4, because it is a better predictor of the occurrence of CVD events than any other cholesterol levels [9] .
Measurement of BMD
Whole-body dual-energy X-ray absorptiometry was performed using a QDR Discovery (formerly known as the QDR 4500A) fan beam densitometer (Hologic, Inc., Bedford, MA, USA) following the procedures recommended by the manufacturer. All subjects were dressed in light clothing and were not wearing jewelry and other items that could interfere with the results of the examination. BMD was measured at the lumbar spine (LS), total hip (TH), and femoral neck (FN). The results of dual-energy X-ray absorptiometry were analyzed using Hologic Discovery software (version 13.1) and the standard techniques of the Korean Society of Osteoporosis.
Statistical analyses
Data are presented as either means ± standard errors (SEs) or percentages (SE). To compare baseline characteristics and mean variable parameters of dyslipidemia, chi-square test was used for categorical variables and Student's t test or analysis of variance was (p<0.001). Average levels of HDL-C, TG, TG/HDL-C, TC/HDL-C, and LDL-C/HDL-C were also different among the physical activity groups (p<0.01).
We analyzed mean BMD according to various parameters of dyslipidemia at the LS, TH, and FN after adjustment for age and BMI (Table 3) . Men with dyslipidemia and high levels of TG, TG/HDL-C, TC/ HDL-C, NHDL-C, and LDL-C/HDL-C had lower BMD than men without dyslipidemia at the LS, TH, and FN (all p<0.01). Men with low HDL-C levels had lower TH and FN BMD than those without dyslipidemia (p=0.062 and 0.024, respectively). Men with high TC had lower LS and FN BMD than those without dyslipidemia (p=0.003 and 0.025, respectively). Table 4 shows the ORs and 95% CIs of an increase in BMD (per standard deviation) for various param- at the FN. The OR for low HDL-C level was 0.886 (0.795-0.987) at the FN. In model 2, ORs for high levels of TG, TG/HDL-C, TC/HDL-C, and NHDL-C were also <1 at all 3 sites. The OR for dyslipidemia and high LDL-C/HDL-C was 0.870 (0.766-0.988) at FN and 0.905 (0.820-0.999) at LS, respectively. The relationship between BMD and dyslipidemic indexes was also inversely related after adjusting with all covariates except HDL-C (Supplement Table 1 ).
eters of dyslipidemia. We adopted 2 logistic regression models. In model 1, we analyzed the ORs (95% CIs) with adjustment for age and BMI; in model 2, we adjusted for covariates in model 1 plus education level, monthly income, alcohol consumption, smoking, physical activity, and daily energy and fat intake. In model 1, all ORs for high levels of TG, dyslipidemia, high TG/HDL-C, TC/HDL-C, NHDL-C, and LDL-C/ HDL-C were <1 at all 3 sites. The OR for high TC was 0.820 (0.713-0.942) at the LS and 0.822 (0.686-0.986) BMD, bone mineral density; KNHANES, Korean National Health and Nutrition Examination Survey; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; NHDL-C, non-high-density lipoprotein cholesterol; LS, lumbar spine; TH, total hip; FN, femoral neck.
Discussion
In this study, we found that LS, TH, and FN BMD are inversely associated with TG, TG/HDL-C, TC/ HDL-C, and NHDL-C levels after adjustment for all covariates in South Korean men.
Osteoporosis and dyslipidemia are both asymptomatic and progress slowly, so it is difficult to diagnose these diseases in the early phase. Some studies have shown a positive relationship between osteoporosis and dyslipidemia, but others could not show a consistent relationship.
Brownbill et al. [28] found that TC and TG levels were positively associated with the total body and femoral shaft BMD, respectively, in postmenopausal women. In addition, Adami et al. [19] found that TG and LDL-C levels were positively associated with the BMDs of the TH and LS in Italian men and women. Turkish postmenopausal women with spinal fractures had lower levels of TC, TG, and LDL-C than those without fractures [29] . However, other studies have suggested that dyslipidemia is inversely correlated with BMD [17, 30, 31] . Orozco found that postmenopausal women with hyperlipidemia had a higher prevalence of low BMD at the LS and FN [30] . In a Japanese study, LDL-C level was inversely correlated with BMD in postmenopausal women with vertebral fracture [17] . In a Korean study, TC and LDL-C levels were inversely correlated with LS and femoral BMD but HDL-C level was not correlated with BMD in both premenopausal and postmenopausal women [31] . Another Korean study also found an inverse relationship between TG and FN BMD in postmenopausal women [23] .
Some studies have shown no correlation between dyslipidemia and low BMD. In a Taiwanese study involving 5,000 individuals (2,170 men and 2,830 women), there was no correlation between TC, TG, and LDL-C levels and low BMD [32] . Solomon et al. examined 13,592 participants in the National Health and Nutritional Examination Survey III and found that there was no significant relationship between TC, LDL-C, or HDL-C levels and BMD after adjustment for covariates [20] . Therefore, there are still controversies in the direction of the relationship between lipid levels and BMD.
Because the aforementioned studies that used single parameters for the definition of dyslipidemia, such as TC, TG, LDL-C, and HDL-C, had controversial conclusions in the relationship between dyslipidemia and BMD, we used other surrogate parameters for dyslipidemia: TG/HDL-C, TC/HDL-C, LDL-C/HDL-C, and 0.882 (0.772-1.009) Model 1 is adjusted for age and BMI, and model 2 is adjusted for variables in model 1 plus education level, monthly income, alcohol consumption, smoking, physical activity, and daily energy and fat intake. ORs, odds ratios; CIs, confidence intervals; BMD, bone mineral density; SD, standard deviation; KNHANES, Korea National Health and Nutrition Examination Survey; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; NHDL-C, non-high-density lipoprotein cholesterol. NHDL-C. Many studies, including prospective epidemiologic studies, have shown that an increased TG/ HDL-C level was correlated with small dense LDL particles, phenotype B, which is associated with an elevated risk of coronary heart disease [4, 33] . In contrast, low TG/HDL-C and low TC/HDL-C levels were correlated with increased large-size HDL subclasses [5] , which have anti-atherogenic functions by reverse cholesterol transport [34] . According to recent meta-analyses, TC/HDL-C level is also an important predictor of the risk of CVD [35, 36] .
Some hypothetical mechanisms have been suggested to explain the negative relationship between BMD and dyslipidemia. These hypotheses are based on some shared mechanisms in low BMD and dyslipidemia [37] [38] [39] [40] [41] [42] [43] . One of the mechanisms is the mevalonate pathway, which is associated with both the regulation of apoptosis or proliferation of bone cells and the synthesis of cholesterol. Tintut et al. reported that LDL-C promotes the differentiation of osteoclasts in vitro and results in elevated activity of osteoclasts in dyslipidemic mice [43] . Moreover, markers for bone remodeling, such as collagen type 1 N-terminal telopeptide and bone alkaline phosphatase, are positively associated with hypercholesterolemia in Japanese patients [40] .
Another mechanism is based on the effect of bisphosphonates. The use of bisphosphonates can decrease the arteriosclerotic process, as shown by the effect on the synthesis of cholesterol in animal studies [38] . Although the anti-atherogenic effect of bisphosphonates is controversial in human studies, some investigators have shown the positive effects of bisphosphonates on lipid metabolism. The use of alendronate was inversely related with decreased TC, LDL-C, and TG levels and carotid intima-media thickness in postmenopausal women [44] . The other agent, neridronate, was also associated with increased HDL-C, HDL-C/LDL-C, and apolipoprotein A-I/apolipoprotein B levels [45] .
In addition to these mechanisms, genetic and hormonal mechanisms explain this relationship. A polymorphic mutation in apolipoprotein E genotype is also correlated with low BMD in perimenopausal women [46] . The mutation of LRP5 or LRP6 gene, which regulates the proliferation of osteoblasts [47] , can also cause low BMD in animals and humans [48] [49] [50] . In addition, it is well known that the level of testosterone, which stimulates bone formation, is correlated with scavenger receptor B1 and the activities of hepatic lipase are related to the metabolism of HDL-C [51] .
Therefore, decreased levels of testosterone are correlated with low HDL-C levels in middle-aged men in some studies [52, 53] .
An increase in oxidized LDL-C level is also associated with low BMD. Oxidized LDL-C, which is common in phenotype B of LDL-C, enhances inflammation of the arterial wall and formation of atherosclerotic plaque and inhibits the differentiation and calcification of osteoblasts in vitro [41, 42] . This results from the activity of T lymphocytes, which plays a key role in osteoclastogenesis [39] . Mice fed a high-fat diet have been shown to develop dyslipidemia and osteopenia at the femoral and tibial bones, and there are increased inflammatory profiles of T lymphocytes isolated from the spleen [18, 39] . In the same manner, we found an inverse relationship between BMD and TG/HDL-C, TC/HDL-C, and NHDL-C that is related to LDL-C, phenotype B.
Our study had several limitations. First, this was a cross-sectional study, so it is impossible to reveal a causal relationship between low BMD and dyslipidemia. Therefore, further prospective studies are needed. Second, we measured TC, LDL-C, HDL-C, and TG levels only once at baseline, so a potential bias such as regression dilution of HDL-C and TG may have existed [54] . Third, we could not measure the testosterone level, subtype of LDL particles, and inflammatory profiles such as C-reactive protein.
Despite these limitations, our study had several strengths. To the best of our knowledge, this was the first study to examine the association between dyslipidemia and BMD at the FN, TH, and LS using a representative sample of Korean men. The other strength was that we used novel surrogate parameters for dyslipidemia and verified that atherogenic parameters of dyslipidemia such as TG/HDL-C, TC/HDL-C, and NHDL-C were better than the traditional lipid profile to explain the inverse relationship between low BMD and dyslipidemia. Third, we adjusted for various covariates on data analysis, such as daily fat and energy intake, in addition with age, BMI, education level, monthly income, alcohol consumption, smoking, and physical activity.
In conclusion, dyslipidemia is related to low BMD after adjusting for covariates. Among various novel parameters for dyslipidemia, TG/HDL-C, TC/HDL-C, and NHDL-C levels were more closely correlated with low BMD. In clinical practice, we recommend careful examination for atherogenic dyslipidemia in men with low BMD. In addition, because low BMD is related to atherogenic dyslipidemia in Korean men, further pro-KNHANES.
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